S

    Scienture Holdings, Inc. (SCNX)

    Official site

    HEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ

    $0.39
    -0.01 (-1.40%)

    Market Cap: $16.18M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    36%(8/22)
    Avg Surprise
    -3033.65%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.06
    Range$-0.06 - $-0.06
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.18-200.0%
    60d ago$-0.08-33.3%
    30d ago$-0.08-33.3%
    7d ago$-0.08-33.3%
    Current$-0.06
    Revenue Consensus
    $2M
    Range$2M - $2M
    1 analysts
    Dec 31, 2026
    EPS Consensus$0.14
    Range$0.14 - $0.14
    1 analysts
    Revenue Consensus
    $3M
    Range$3M - $3M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.14---
    Sep 26EST
    		-$-0.06---
    Jun 26
    		$-0.07$-0.09+22.22%Beat+85.4%
    Mar 26
    		$-0.08N/A+63.64%Beat+75.4%
    Dec 25
    		$-0.13N/A+53.57%Beat+83.5%
    Sep 25
    		$-0.19$0.00N/AMiss+85.8%
    Jun 25
    		$-0.48N/AN/ABeat+63.2%
    Mar 25
    		$-0.33N/AN/ABeat-101.6%
    Dec 24
    		$-0.79$0.38-307.89%Miss+93.9%
    Sep 24
    		$-1.34N/AN/ABeat+70.7%
    Jun 24
    		$-1.30N/AN/ABeat+55.0%
    Mar 24
    		$20.49N/AN/ABeat+29375.4%
    Dec 23
    		$-12.95N/AN/ABeat-763.0%
    Sep 23
    		$-4.57N/AN/ABeat-407.9%
    Jun 23
    		$-2.90$-0.45-544.24%Miss-48.7%
    Mar 23
    		$-0.07$-0.02-250.00%Miss+96.1%
    Dec 22
    		$-1.50$-0.27-448.85%Miss+0.0%
    Sep 22
    		$-0.90$-0.12-682.61%Miss+62.5%
    Jun 22
    		$-1.95$-0.06-3445.45%Miss+59.4%
    Mar 22
    		$-1.80$-0.10-1761.43%Miss-50.0%
    Dec 21
    		$-1.50$-0.14-971.43%Miss+65.5%
    Sep 21
    		$-2.40$-0.12-1900.00%Miss-900.0%
    Jun 21
    		$-4.80$-0.09-5436.33%Miss-357.1%
    Mar 21
    		$-1.20$-0.06-2016.40%Miss-500.0%
    Dec 20
    		$-4.35$0.01-43600.00%Miss-262.5%
    Sep 20
    		$0.30$0.03+900.00%Beat+338.6%
    Jun 20
    		$-1.05$0.01-10600.00%Miss-831.7%
    Mar 20
    		$0.30$0.01+2900.00%Beat-4.2%
    Dec 19
    		$-1.20$0.06-2100.00%Miss-11900.0%
    Sep 19
    		$0.07$0.01+584.00%Beat-72.0%
    Jun 19
    		$0.14$0.01+1335.00%Beat+168.2%
    Mar 19
    		$0.31$0.02+1466.00%Beat+44.1%
    Dec 18
    		$-0.01N/AN/ABeat-102.5%
    Sep 18
    		$0.24N/AN/ABeat+21.4%
    Jun 18
    		$0.05N/AN/ABeat+377.2%
    Mar 18
    		$0.22N/AN/ABeat+3.8%
    Dec 17
    		$0.39N/AN/ABeat-
    Sep 17
    		$0.20N/AN/ABeat+107.5%
    Jun 17
    		$-0.02N/AN/ABeat-
    Mar 17
    		$0.21N/AN/ABeat-
    Dec 16
    		$0.00$0.00N/ABeat-
    Sep 16
    		$-2.70N/AN/ABeat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00

    Key Metrics

    Valuation
    P/E Ratio-0.83EV/EBITDA-1.57x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-786.00%
    ROE-53.50%ROIC-47.05%
    Financial Health
    Debt/Equity0.17xInterest Coverage-12.08x
    Current Ratio3.04xQuick Ratio2.97x
    Trading Statistics
    Beta3.96Avg Volume3.35M
    52-Week High$2.6052-Week Low$0.24

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.42
    SMA 20$0.42
    SMA 50$0.39
    SMA 200$0.44
    EMA 10$0.41
    EMA 20$0.41
    EMA 50$0.40
    EMA 200$0.54

    MACD

    Line: 0.00Signal: 0.01Hist: -0.01

    ADX

    ADX: 20.8+DI: 12.2-DI: 21.6

    Aroon & PSAR

    Aroon Up72.0
    Aroon DownN/A
    PSAR$0.47

    Bollinger Bands

    Upper Band$0.50
    Lower Band$0.35
    %B Position3532%(Upper)
    Band Width0.28

    RSI (14-Day)

    Neutral
    43.7

    Momentum Oscillators

    Stoch %K19.9
    Stoch %D20.9
    Williams %R-79.3
    ROC (10d)-17.2%
    Momentum-0.08
    CCI (20d)-71.7
    MFI (14d)52.4

    Volatility Measures

    ATR (14d)$0.03(8.6%)
    StdDev (20d)0.04
    Hist Vol71.6%(High)

    Volume Flow

    VWAP$0.39
    OBV975.8M
    AD Line222.2M
    CMF (20d)0.658

    Volume Metrics

    Avg Vol (20d)3.5M
    Vol Ratio0.0x(Low)
    VWMA (20d)$0.45

    Pivot Points

    R3$0.42
    R2$0.41
    R1$0.40
    Pivot Point$0.39
    S1$0.38
    S2$0.37
    S3$0.36

    Advanced Oscillators

    TSI2.01
    Ultimate Osc42.8
    KST135.68

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$343,639$56,325$-168,699$590,050$0$10,258$53,083$64,861$18,699$0$111,702$392,286
    Cost of Revenue$7,860$2,475$75,113$15,429$0$9,585$50,258$60,978$19,402$0$242,622$352,694
    Gross Profit$335,779$53,850$-243,812$574,621$0$673$2,825$3,883$-703$0$-130,920$39,592
    Operating Expenses$3.03M$3.55M$29.16M$4.94M$5.16M$3.57M$4.22M$3.50M$1.49M$5.49M$2.10M$801,270
    R&D$1.17M$793,984$368,698$169,344$843,549$574,679$982,707$1.25M$0$0$0$0
    SG&A$1.33M$2.01M$1.94M$3.49M$3.14M$1.77M$1.57M$762,013$924,557$4.88M$1.11M$362,377
    Operating Income$-2,699,733$-3,509,499$-29,500,413$-4,361,206$-5,157,906$-3,571,317$-4,214,562$-3,497,791$-1,495,691$-5,492,971$-2,228,901$-761,678
    Interest Income$147,147$133,344$212,992$1,120$63,148$25,442$1,940$29,445$41,031$62,921$0$0
    Interest Expense$269,785$37,019$955,499$1.80M$653,493$670,784$1.01M$217,433$4,949$98,515$648,319$251,778
    Income Before Tax$-2,822,371$-3,402,264$-30,115,211$-3,607,361$-6,720,573$-3,063,997$-7,337,112$-3,183,601$-1,624,741$-6,633,422$-5,029,056$-88,136
    Income Tax Expense$0$0$-1,994,878$0$0$0$-534,396$0$0$0$0$0
    Net Income$-2,822,371$-3,402,264$-28,120,333$-3,607,361$-6,720,573$-3,063,997$-7,162,732$-3,183,601$-1,833,902$21.25M$-11,665,629$-3,525,114
    EBITDA$-2,141,226$-3,030,576$-28,165,597$-42,748$-5,629,249$-1,894,513$-5,410,992$-2,959,797$-1,652,460$-6,589,525$-3,665,287$392,182
    EBIT$-2,699,733$-3,498,589$-29,031,054$-1,805,051$-6,130,228$-2,418,655$-6,324,318$-2,995,613$-1,660,823$-6,597,828$-4,380,737$163,642
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SCNX

    News

    SCNX | Scienture Holdings, Inc. Common Financials - Revenue Breakdown

    This article provides a detailed financial overview for Scienture Holdings, Inc. (SCNX), focusing on its revenue breakdown. It covers various aspects including Congress trading, insider trading activity, institutional holdings, corporate lobbying, and analyst ratings, but notes that specific revenue breakdown data by segment or geography is currently unavailable. The company is described as a health services and pharmaceutical product company specializing in cardiovascular and central nervous system diseases.

    Quiver Quantitative•8/23/26•
    Neutral

    Scienture stock jumps 21% on REZENOPY commercial launch

    Scienture Holdings (NASDAQ: SCNX) saw its stock jump 21.25% after announcing the completion of commercial launch inventory for REZENOPY, a 10 mg naloxone nasal spray. Shipments to U.S. wholesalers are set to begin in July, with retail availability expected in August. The product targets the $144 million U.S. naloxone market and has expanded payer access to cover over 100 million lives.

    scanx.trade•8/23/26•
    Bullish

    Scienture Q2 Revenue Reaches $343,639 as Net Loss Narrows 58%

    Scienture Holdings (SCNX) reported a significant increase in Q2 2026 revenue to $343,639, a 510% sequential jump, while narrowing its net loss by 58% to $2.8 million. The company achieved a 97.7% gross margin and launched its second commercial product, REZENOPY. Additionally, institutional investors showed varied activity in SCNX stock, with several hedge funds adding shares to their portfolios.

    Quiver Quantitative•8/20/26•
    Bullish

    $Scienture Holdings (SCNX.US)$ LMAO. They give us a buy rating, but wont let us buy.

    An investor comments on Scienture Holdings (SCNX.US), humorously pointing out the irony of the stock receiving a "buy" rating while simultaneously being unavailable for purchase. The comment expresses frustration over this perceived contradiction.

    Moomoo•8/19/26•
    Somewhat-Bearish

    Scienture Holdings 2Q Loss/Shr 7c >SCNX

    Scienture Holdings reported a second-quarter loss of 7 cents per share. Additionally, Unity Software reported its fourth-quarter financial results with revenue increasing 35% year-over-year to $609 million, exceeding estimates, despite reporting a quarterly loss of 66 cents per share. The article provides financial data for both companies.

    Moomoo•8/14/26•
    Bearish

    Frequently Asked Questions About SCNX

    Does SCNX pay dividends?
    Scienture Holdings, Inc. (SCNX) has a dividend payment track record. See the SCNX dividend history page for its current payment status, yield, and streaks.
    What is SCNX's market cap?
    Scienture Holdings, Inc. (SCNX) has a market capitalization of $16.18M with a current stock price of $0.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In